Safety and Yield of Diagnostic ERCP in Liver Transplant Patients with Abnormal Liver Function Tests

Table 1

Demographics and laboratory investigations of patients entered into the study.

Age, median (IQR)	55 (48–62)
Sex, 𝑁 (%)
Female	79 (37.6)
Male	131 (62.4)
Race, 𝑁 (%)
Caucasian	176 (83.8)
African-American	30 (14.3)
Other	4 (1.9)
Liver function test, median (range)
Total bilirubin	2.5 (0.2–36.5)
AST	78 (12–1375)
ALT	109 (9–1022)
Alkaline phosphatase	277 (51–1625)
GGT	339 (24–2050)

AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma glutamyl transferase.